NIVIEN THERAPEUTICS
Nivien Therapeutics developed the first small molecule inhibitors of the Hippo signaling pathway. Read the Nivien story in The Washington Post: https://www.washingtonpost.com/national/health-science/heres-what-happened-when-i-tried-to-develop-a-new-drug-for-a-deadly-cancer/2019/01/11/
NIVIEN THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2016-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.nivientherapeutics.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
600 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Google Apps For Business Google GStatic Google Static Content Google Cloud Sectigo SSL
Current Employees Featured
Founder
Investors List
Third Kind Venture Capital
Third Kind Venture Capital investment in Seed Round - Nivien Therapeutics
SOSV
SOSV investment in Seed Round - Nivien Therapeutics
IndieBio
IndieBio investment in Seed Round - Nivien Therapeutics
Newest Events participated
Official Site Inspections
http://www.nivientherapeutics.com Semrush global rank: 6.16 M Semrush visits lastest month: 1.31 K
- Host name: apache2-bongo.ams1-shared-01.dreamhost.com
- IP address: 66.33.215.152
- Location: Brea United States
- Latitude: 33.9339
- Longitude: -117.8854
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 92821
More informations about "Nivien Therapeutics"
Nivien Therapeutics - Crunchbase Company Profile & Funding
Nivien Therapeutics is developing the first small molecule drugs to enhance both chemo and immunotherapies.See details»
Nivien Therapeutics Company Profile 2024: Valuation, …
Developer of first small molecule drugs designed to enhance both chemo and immunotherapies. The company's program de-risks transfers of tech assets from top research institutes, it is also developing a novel platform to enhance IO …See details»
Nivien Therapeutics - Craft
Nivien Therapeutics is a company developing small molecule drugs to enhance chemo and immunotherapies. It aims to kill the shields that cancer uses to resist treatment. See insights …See details»
www.nivientherapeutics.com
Www.nivientherapeutics.comSee details»
Nivien Therapeutics - Funding, Financials, Valuation & Investors
Nivien Therapeutics is developing the first small molecule drugs to enhance both chemo and immunotherapies.See details»
Nivien Therapeutics | VentureRadar
Nivien Therapeutics is developing the first small molecule drugs to enhance both chemo and immunotherapies. Their compounds overcome multiple resistance mechanisms across 15 …See details»
Nivien Therapeutics Co. - Drug pipelines, Patents, Clinical trials ...
Explore Nivien Therapeutics Co. with its drug pipeline, therapeutic area, technology platform, .See details»
Nivien Therapeutics - Crunchbase
Nivien Therapeutics is developing the first small molecule drugs to enhance both chemo and immunotherapies.See details»
MCB Concentrator to Build Biotech Startup - Harvard …
Dec 21, 2017 · Horwitz has left Harvard to found Nivien Therapeutics, along with his business partner Nikita Shah, who graduated from Harvard this spring. They plan to develop cancer therapies based on research conducted by Marc …See details»
Two Harvard Biotech Entrepreneurs Are Creating The …
Mar 30, 2018 · Two Harvard researchers turned entrepreneurs are engineering drug therapies to increase the effectiveness of available treatments and decrease cancer patients’ emotional, physical, and financial...See details»
What a Researcher Learned Developing a New Drug for Pancreatic …
Feb 25, 2019 · In the following interview with Horwitz, we explore what drew him to research and drug development, what he learned from his experiences with Nivien and why he feels clinical …See details»
What happened when biotech startup pursued a new treatment …
Jan 11, 2019 · Here’s what happened when I tried to develop a new drug for a deadly cancer. Nathaniel Brooks Horwitz and Nikita Shah at the Nivien Therapeutics lab in San Francisco. …See details»
Nivien Therapeutics - VentureRadar
Dec 28, 2018 · Nivien Therapeutics is developing the first small molecule drugs to enhance both chemo and immunotherapies. Their compounds overcome multiple resistance mechanisms …See details»
Nivien's Shot - Science | AAAS
Jan 15, 2019 · Have you ever heard of Nivien Therapeutics? Unless you follow the oncology world pretty closely, probably not. But they are - well, were - a startup out of Harvard that was …See details»
Nivien Therapeutics - Contacts, Employees, Board Members
Find more contact data in Search! Nivien Therapeutics has 2 current employee profiles, including President & CFO Nikita Shah. Nivien Therapeutics is developing the first small molecule drugs …See details»
How a failed scientific start-up can breed success - Nature
May 29, 2019 · He had co-founded a company, Nivien Therapeutics, to create a drug that would make chemotherapy work more effectively. He and his team had designed a small molecule to …See details»
Research programme : anti-cancer therapeutics - Nivien …
Nivien Therapeutics, based on biology from Harvard Medical School, is developing therapeutics for the treatment of cancer, with the initial focus on pancreaticSee details»
The Biotech Startup Taking on Pancreatic Cancer by Throwing Out …
Feb 21, 2018 · In December, I left my senior year at Harvard to launch Nivien Therapeutics, a biotechnology startup that is taking a novel approach to fighting these cancers based on …See details»
How These Harvard Grads Are Changing Cancer Medication
May 9, 2018 · In the words of Nathaniel Brooks Horwitz and Nikita Shah (Co-founders of Nivien Therapeutics), they are doing this to increase the effectiveness of existing Cancer treatments, …See details»
Nivien Therapeutics: Cutting Through Cancer’s Shield - IndieBio
Apr 12, 2018 · Our mission is to dramatically improve the standard-of-care in cancer therapeutics. What milestones are you aiming to hit in the near future? We are filing key patents, …See details»